MedTrace Logo

TGIR Randomized Placebo-controlled Healthy Subject Study

NCT05783193 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-03-24

No results posted yet for this study

Summary

The primary research objective of this study is to confirm the absence of side-effects and explore any analgesic properties of the botanical formulation TGIR (Traditional Gastrointestinal Remedy) in healthy participants.

Conditions

  • Healthy

Interventions

DRUG

TGIR (Traditional Gastrointestinal Remedy)

TGIR botanical formulation

DRUG

Placebo

Placebo capsules

Sponsors & Collaborators

  • Resilience Biosciences Inc (RBI)

    collaborator UNKNOWN

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Pouya Rezazadeh-Azar, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05783193 on ClinicalTrials.gov